Design, synthesis and antitumor activity of novel D-glucuronic acid derivatives. 2011

Ahmed O H el-Nezhawy, and Frady G Adly, and Ahmed F Eweas, and Atef G Hanna, and Yehya M el-Kholy, and Shahenaz H el-Syed, and Tarek B A el-Naggar
Chemistry of Natural and Microbial Products Department, National Research Center, Dokki, Cairo, Egypt. nzhawy7@yahoo.com

A series of D-glucuronic acid derivatives were chemically synthesized including acetylated and deacetylated glucuronamides, as well as N-glucuronides starting from the D-glucuronic acid itself by means of protection/deprotection, activation and condensation protocols. Structure elucidation of all products along with optimization of the synthetic steps is described. The synthesized compounds were evaluated for their in vitro antitumor activity against MCF-7, TK-10 and UACC-62 cell lines. The compounds 4, 5, 7, 8, 14, 16 and 18 were the most active against TK-10 cell line. On the other hand, the most active compounds against the MCF-7 cell line were 9, 18 and 20. However, compounds 7-10 13-15 and 17 were the most active against the UACC-62 cell line.

UI MeSH Term Description Entries
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Ahmed O H el-Nezhawy, and Frady G Adly, and Ahmed F Eweas, and Atef G Hanna, and Yehya M el-Kholy, and Shahenaz H el-Syed, and Tarek B A el-Naggar
September 2017, Molecules (Basel, Switzerland),
Ahmed O H el-Nezhawy, and Frady G Adly, and Ahmed F Eweas, and Atef G Hanna, and Yehya M el-Kholy, and Shahenaz H el-Syed, and Tarek B A el-Naggar
July 2019, Journal of Asian natural products research,
Ahmed O H el-Nezhawy, and Frady G Adly, and Ahmed F Eweas, and Atef G Hanna, and Yehya M el-Kholy, and Shahenaz H el-Syed, and Tarek B A el-Naggar
January 2012, Scientia pharmaceutica,
Ahmed O H el-Nezhawy, and Frady G Adly, and Ahmed F Eweas, and Atef G Hanna, and Yehya M el-Kholy, and Shahenaz H el-Syed, and Tarek B A el-Naggar
October 2017, Journal of Asian natural products research,
Ahmed O H el-Nezhawy, and Frady G Adly, and Ahmed F Eweas, and Atef G Hanna, and Yehya M el-Kholy, and Shahenaz H el-Syed, and Tarek B A el-Naggar
January 2016, Journal of Asian natural products research,
Ahmed O H el-Nezhawy, and Frady G Adly, and Ahmed F Eweas, and Atef G Hanna, and Yehya M el-Kholy, and Shahenaz H el-Syed, and Tarek B A el-Naggar
June 2016, Bioorganic chemistry,
Ahmed O H el-Nezhawy, and Frady G Adly, and Ahmed F Eweas, and Atef G Hanna, and Yehya M el-Kholy, and Shahenaz H el-Syed, and Tarek B A el-Naggar
January 2011, Chemical & pharmaceutical bulletin,
Ahmed O H el-Nezhawy, and Frady G Adly, and Ahmed F Eweas, and Atef G Hanna, and Yehya M el-Kholy, and Shahenaz H el-Syed, and Tarek B A el-Naggar
October 2017, Bioorganic & medicinal chemistry,
Ahmed O H el-Nezhawy, and Frady G Adly, and Ahmed F Eweas, and Atef G Hanna, and Yehya M el-Kholy, and Shahenaz H el-Syed, and Tarek B A el-Naggar
December 2020, Bioorganic chemistry,
Ahmed O H el-Nezhawy, and Frady G Adly, and Ahmed F Eweas, and Atef G Hanna, and Yehya M el-Kholy, and Shahenaz H el-Syed, and Tarek B A el-Naggar
January 2022, Frontiers in pharmacology,
Copied contents to your clipboard!